This means thyroid labs should be rechecked 6 to 8 weeks after starting semaglutide, then periodically as weight stabilizes
Most GLP-1R agonists are safe to use
Peptides can bring focused impact and less widespread side effects
Individuals suffering from conditions like irritable bowel syndrome (IBS), Crohn's disease, ulcers, and leaky gut syndrome may benefit from its reported ability to repair the digestive tract lining
[8] [20] Beyond nausea, patients commonly experience a constellation of gastrointestinal symptoms including: Vomiting (reported in 24% of semaglutide users) Diarrhea (affecting 30% of patients) Constipation (occurring in 24% of users) Abdominal pain or discomfort (experienced by 20% of patients) Bloating and excessive gas Acid reflux or heartburn Decreased appetite (which, while therapeutic, can feel uncomfortable) The severity of these symptoms typically ranges from mild to moderate, and most patients do not discontinue treatment due to nausea alone
This adaptation typically begins 816 weeks into treatment and affects roughly 3040% of users
